Document is current
Any future updates will be listed below
-
Authors
Bot, Adrian
Stephan, Matthias T.
Gill, Saar
- License Information
-
More Information
Article History
First Online: 22 January 2026
Competing interests
: A.B. is a consultant for AbbVie Inc, Cartesian Therapeutics, Elicio Therapeutics and A2 Biotherapeutics. M.T.S. is co-founder of and has received stock options from Persistence Therapeutics (Jupiter Bioventures) and has intellectual property licensing with Sanofi, Juno Therapeutics (now Bristol Myers Squibb) and Jupiter Bioventures. S.G. is a named inventor on multiple patents related to CAR-T cells, including in vivo transduction, that have been filed by the University of Pennsylvania, and he has received research funding from Novartis Pharmaceuticals. He is a consultant for AvenCell, Curris, Ship of Theseus, Cassidy Bio and Yellowstone.
